Red X iconGreen tick iconYellow tick icon
Professor Rebecca GraingerMBChB (Dstn), BMedSci (Dstn) MIsntD, FHiNZ, FRACP, PhD

Professor, Department of Medicine
Rheumatologist, Te Whatu Ora Capital Coast and Hutt Valley

Tel +64 4 806 1031
Email rebecca.grainger@otago.ac.nz

Rebecca is an academic rheumatologist who is passionate about patient-focused care and engaging with colleagues in primary and secondary care to provide the highest quality collaborative care for people with arthritis.

A University of Otago medical graduate, she undertook rheumatology training in Melbourne and her PhD examined inflammatory mechanisms in gout.

Rebecca's clinical work focuses on assessment and management of inflammatory arthritis and her particular clinical interests include inflammatory arthritis, gout, and scleroderma. Rebecca's academic interests are wide but she aims to undertake research in clinical rheumatology, health professions education and technology.

Research and Interests

  • Development and assessment of mobile health tools for clinical care and self-care for clinicians and health care users
  • Social media for participatory health and medical education
  • Enhancing engagement and active learning in medical education
  • Outcome measures in musculoskeletal and rheumatic disease
  • Gout including inflammatory mechanisms, pharmacological treatment and clinical assessment

I am interested in supervising postgraduate students in any of the research areas listed above. Please contact me directly by email.

Publications

Kanagasabai, P., Filoche, S., Henry, C., Ormandy, J., Te Whaiti, S., & Grainger, R. (2024). Women’s experience of participating in a storytelling intervention about abnormal uterine bleeding for medical student education. Focus on Health Professional Education, 25(3), 16-25. doi: 10.11157/fohpe.v25i3.783 Journal - Research Article

Grainger, R., Milne, V., Ngan Kee, R., & Dalbeth, N. (2024). National survey of hospital rheumatology service users to inform a statement set describing the minimum service expectations for publicly funded rheumatology secondary care in Aotearoa New Zealand. New Zealand Medical Journal/Te ara tika o te hauora hapori, 137(1603), 33-78. Retrieved from https://journal.nzma.org.nz/ Journal - Research Article

Chan, S. J., Stamp, L. K., Treharne, G. J., Cheung, J. M. Y., Dalbeth, N., Grainger, R., Stebbings, S., & Marra, C. A. (2024). Preferences for tapering biologic disease-modifying antirheumatic drugs among people with rheumatoid arthritis: A discrete choice experiment. Arthritis Care & Research. Advance online publication. doi: 10.1002/acr.25437 Journal - Research Article

Taylor, W. J., Dalbeth, N., Kain, T., White, D., Grainger, R., & Quincey, V. (2024). Time to start disease modifying drugs for adults with seropositive rheumatoid arthritis: Results of the first year of the national New Zealand Rheumatology Association (NZRA) audit. New Zealand Medical Journal/Te ara tika o te hauora hapori, 137(1600), 21-30. Retrieved from https://www.nzmj.org.nz/ Journal - Research Article

Grainger, R., Bourke, J., Martin, R., & Caldwell, J. (2024). The need for active allies: A narrative analysis of disable medical students' perspectives of their medical school in Aotearoa New Zealand. Proceedings of the Australian & New Zealand Association for Health Professional Educators (ANZAHPE) Conference. 143. Retrieved from https://www.anzahpe.org/ Conference Contribution - Published proceedings: Abstract

Back to top